Nefopam hydrochloride loaded microspheres for post-operative pain management: synthesis, physicochemical characterization and in-vivo evaluation

References

• De Jong WH, Borm PJA. Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine. 2008;3:133–149.
   PubMed Web of Science ®Google Scholar
• Aymard G, Warot D, Demolis P, et al. Comparative pharmacokinetics and pharmacodynamics of intravenous and oral nefopam in healthy volunteers. Pharmacol Toxicol. 2003;92:279–286.
   PubMedGoogle Scholar
• Kyung HK, Salahadin A. Rediscovery of nefopam for the treatment of neuropathic pain. Korean J Pain. 2014;27:103–111.
   PubMedGoogle Scholar
• Hamishehkar H, Emami J, Najafabadi AR, et al. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Colloids Surf B Biointerfaces. 2009;74:340–349.
   PubMed Web of Science ®Google Scholar
• Abraham GA, Gallardo A, San Roman J, et al. Polymeric matrices based on graft copolymers of PCL onto acrylic backbones for releasing antitumoral drugs. J Biomed Mater Res. 2003;64:638–647.
   Web of Science ®Google Scholar
• Chun YS, Kim WN. Thermal properties of poly (hydroxybutyrate-co-hydroxyvalerate) and poly (ε-caprolactone) blends. Polymer. 2000;41:2305–2308.
   Web of Science ®Google Scholar
• Marin E, Briceño MI, Caballero-George C. Critical evaluation of biodegradable polymers used in nanodrugs. Int J Nanomedicine. 2013;8:3071–3090.
   PubMed Web of Science ®Google Scholar
• El-Hadi A, Schnabel R, Straube E, et al. Correlation between degree of crystallinity, morphology, glass temperature, mechanical properties and biodegradation of poly (3-hydroxyalkanoate) PHAs and their blends. Polymer Testing. 2002;21:665–674.
   Web of Science ®Google Scholar
• Sinha VR, Bansal K, Kaushik R, et al. Poly-epsilon-caprolactone microspheres and nanospheres: an overview. Int J Pharm. 2004;278:1–23.
   PubMed Web of Science ®Google Scholar
• Youan BB, Benoit MA, Baras B, et al. Protein-loaded poly(epsilon-caprolactone) microparticles. I. Optimization of the preparation by (water-in-oil)-in water emulsion solvent evaporation. J Microencapsul. 1999;16:587–599.
   PubMed Web of Science ®Google Scholar
• Francis L, Meng D, Knowles J, et al. Controlled delivery of gentamicin using poly(3-hydroxybutyrate) microspheres. Int J Mol Sci. 2011;12:4294–4314.
   PubMed Web of Science ®Google Scholar
• Raval JP, Naik DR, Amin KA, et al. Controlled-release and antibacterial studies of doxycycline-loaded poly (ɛ-caprolactone) microspheres. J Saudi Chem Soc. 2014;18:566–573.
   Web of Science ®Google Scholar
• Gajra B, Dalwadi C, Patel R. Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using box behnken design. Daru J Pharm Sci. 2015;23:3–18.
   Web of Science ®Google Scholar
• Natarajan V, Krithica N, Madhan B, et al. Formulation and evaluation of quercetin polycaprolactone microspheres for the treatment of rheumatoid arthritis. J Pharm Sci. 2011;100:195–205.
   PubMed Web of Science ®Google Scholar
• D’Souza S. A review of in-vitro drug release test methods for nano-sized dosage forms. Adv Pharm. 2014;2014:1–12.
   Google Scholar
• Kumar A, Sawant K. Encapsulation of exemestane in polycaprolactone nanoparticles: optimization, characterization, and release kinetics. Cancer Nanotechnol. 2013;4:57–71.
   PubMedGoogle Scholar
• Singh S, Muthu MS. Studies on biodegradable polymeric nanoparticles of risperidone: in vitro and in vivo evaluation. Nanomedicine (Lond). 2007;3:305–319.
   Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13:123–133.
   PubMed Web of Science ®Google Scholar
• Khatik R, Dwivedi P, Shukla A, et al. Development, characterization and toxicological evaluations of phospholipids complexes of curcumin for effective drug delivery in cancer chemotherapy. Drug Deliv. 2016;23:1057–1068.
   PubMed Web of Science ®Google Scholar
• Brady LS, Holtzman SG. Analgesic effects of intraventricular morphine and enkephalins in nondependent and morphine-dependent rats. J Pharmacol Exp Ther. 1982;222:190–197.
   PubMed Web of Science ®Google Scholar
• D’Amour FE, Smith DL. A method for determining loss of pain sensation. J Pharmacol Exp Ther. 1941;72:74–79.
   Google Scholar
• Jones CK, Peters SC, Shannon HE. Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents. J Pharmacol Exp Ther. 2005;312:726–732.
   PubMed Web of Science ®Google Scholar
• Brennan TJ, Vandermeulen EP, Gebhart GF. Characterization of a rat model of incisional pain. Pain. 1996;64:493–501.
   PubMed Web of Science ®Google Scholar
• Hamalainen MM, Subieta A, Arpey C, et al. Differential effect of capsaicin treatment on pain-related behaviors after plantar incision. J Pain. 2009;10:637–645.
   PubMed Web of Science ®Google Scholar
• Suto T, Obata H, Tobe M, et al. Long-term effect of epidural injection with sustained-release lidocaine particles in a rat model of postoperative pain. Br J Anaesth. 2012;109:957–967.
   PubMed Web of Science ®Google Scholar
• Whiteside GT, Harrison J, Boulet J, et al. Pharmacological characterisation of a rat model of incisional pain. Br J Pharmacol. 2004;141:85–91.
   PubMed Web of Science ®Google Scholar
• Stuesse SL, Crisp T, McBurney DL, et al. Neuropathic pain in aged rats: behavioral responses and astrocytic activation. Exp Brain Res. 2001;137:219–227.
   PubMed Web of Science ®Google Scholar
• Hargreaves K, Dubner R, Brown F, et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 1988;32:77–88.
   PubMed Web of Science ®Google Scholar
• Zahn PK, Brennan TJ. Primary and secondary hyperalgesia in a rat model for human postoperative pain. Anesthesiology. 1999;90:863–872.
   PubMed Web of Science ®Google Scholar
• Zhou YZ, Alany RG, Chuang V, et al. Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design. Drug Dev Ind Pharm. 2013;39:321–330.
   PubMed Web of Science ®Google Scholar
• Karasulu E, Yeşim Karasulu H, Ertan G, et al. Extended release lipophilic indomethacin microspheres: formulation factors and mathematical equations fitted drug release rates. Eur J Pharm Sci. 2003;19:99–104.
   PubMed Web of Science ®Google Scholar